Table 1.
Number (%) | ||||
---|---|---|---|---|
Total patients (N = 120) | Patients without BCG vaccination (n = 38) | Patients with BCG vaccination (n = 82) | P value | |
Demographic | ||||
Age, median (IQR), years | 39.5 (27.0–50.0) | 31.0 (23.0–61.0) | 41.0 (29.0–49.0) | 0.390 |
Sex | ||||
Male | 30 (25.0) | 10 (26.3) | 20 (24.4) | 0.821 |
Female | 90 (75.0) | 28 (73.7) | 62 (75.6) | |
Ethnicity | ||||
Latino/Hispanic | 105 (87.5) | 31 (81.6) | 74 (90.2) | 0.163 |
Non-Latino/Hispanic | 9 (7.5) | 3 (7.9) | 6 (7.3) | |
Refused | 6 (5.0) | 4 (10.5) | 2 (2.4) | |
Cigarette smoking historya | 9 (7.5) | 6 (15.8) | 3 (3.7) | 0.019 |
Symptoms during disease course | ||||
Cough | 88 (73.3) | 27 (71.1) | 61 (74.4) | 0.701 |
Shortness of breath | 32 (26.7) | 12 (31.6) | 20 (24.4) | 0.407 |
Nasal congestion/rhinorrhoea | 62 (51.7) | 19 (50.0) | 43 (52.4) | 0.804 |
Myalgia | 80 (66.7) | 19 (50.0) | 61 (74.4) | 0.008 |
Fever | 74 (61.7) | 19 (50.0) | 55 (67.1) | 0.074 |
Headache | 72 (60.0) | 21 (55.3) | 51 (62.2) | 0.471 |
Sore throat | 46 (38.3) | 14 (36.8) | 32 (39.0) | 0.819 |
Vomiting/diarrhoea | 47 (39.2) | 19 (50.0) | 28 (34.2) | 0.098 |
Loss of smell/taste | 73 (60.8) | 24 (63.2) | 49 (59.8) | 0.722 |
Outcomes | ||||
Referred to emergency room | 25 (20.8) | 13 (34.2) | 12 (14.6) | 0.014 |
Hospitalised | 9 (7.5) | 6 (15.8) | 3 (3.7) | 0.019 |
Comorbidities | ||||
Hypertension | 29 (24.2) | 10 (26.3) | 19 (23.2) | 0.708 |
Diabetes | 15 (12.5) | 5 (13.2) | 10 (12.2) | 0.882 |
COPD or asthmab | 10 (8.3) | 7 (18.4) | 3 (3.7) | 0.006 |
Morbid obesityc | 23 (19.2) | 6 (15.8) | 17 (20.7) | 0.522 |
Chronic kidney disease | 4 (3.3) | 2 (5.3) | 2 (2.4) | 0.423 |
Liver cirrhosis | 0 | 0 | 0 | |
Immunocompromised | 1 (0.8) | 0 | 1 (1.2) | 0.494 |
IQR, interquartile range; COPD, chronic obstructive pulmonary disease.
Cigarette smoking history: none of the nine hospitalised patients have a cigarette smoking history.
COPD or asthma: among the nine hospitalised patients, two patients without BCG vaccination have COPD or asthma, no patient with BCG vaccination has COPD or asthma (P = 0.257).
Morbid obesity was defined as a BMI of 40 or more, or 35 or more and experiencing obesity-related health conditions, such as hypertension or diabetes.